Navigation Links
Memory Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
Date:11/6/2008

MONTVALE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced that Michael Smith, Chief Financial Officer and Head of Business Development, will provide a company update at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, November 11, 2008 at 11:10 a.m. EST at the New York Palace Hotel, in New York City.

Interested parties may access the live webcast of the presentation by visiting the "Investors" section of Memory Pharmaceuticals' website at http://www.memorypharma.com. Archived versions of the webcast will be available at the same location for one week following the presentation.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com.


'/>"/>
SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
2. Scientists synthesize memory in yeast cells
3. Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster
4. Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster
5. Scientists synthesize memory in yeast cells
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
8. ASU researchers improve memory devices using nanotech
9. Memory Pharmaceuticals to Announce Third Quarter Results on Thursday, November 8, 2007
10. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
11. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , LIBREVILLE, Gabon, December 2 /PRNe...n Africa: Everyone,s Problem and Heritage" , ...iversity, 2-3 June 2010 the,Gabonese Republic is h...Gabon) on the issue of safeguarding biological res...by government and state leaders, ministers,scient...
(Date:12/2/2009)..., , CAMBRIDGE, Mass., Dec. 2 /PRNewswi...er the leaders in technology development and produ... MEMS, announced the December 11th deadline for te..., Now in its 14th year, TechConnect World, in ass...itute (NSTI), and the Clean Technology and Sustain...
(Date:12/2/2009)..., , SINGAPORE, Dec. 2 ...n its novel oral JAK2 inhibitor, SB1518, at The Am...nd Exposition in New Orleans. ,, Data will be p...dose-escalation trial of SB1518 detailing its safe...ic (PK/PD) profile in dose levels ranging from 100...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewswir... or the "Company") (NYSE: SCR ), a leading pharm... manufacturing, and marketing of branded,generic a...ounced that 105 of,its drugs have been included in..., which was issued by China,s Ministry of Human Re...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
... large quantities of difficult-to-express proteins... ,Biochemical & Molecular Allergology, Research ...L21-CodonPlus(DE3)-RIL cells * with,extra copies... is possible to attain high-level expression of di...PTG-induced expression of several recombinant pean...
...embryonic cell lines are useful for in vitro mutag...atagene Cloning Systems, Inc. , The Big Blue rat...onic,cell line are useful for in vitro mutagenes... Blue transgenic rodent mutagenesis assay system,*...nown mutagens in a variety of tissues from,trans...
... for neuroscience research , , , Danny Q. ...gerelli ,Stratagene Cloning Systems, Inc. , ,...es for NMDA receptor,subunits that are useful fo...,subunit proteins in different cell types and brai...stern blot analysis of rat brain to study expressi...
Other Biology Technology:High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 2High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 3High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 4Big Blue Rodent Cell Cultures for Mutagenesis Studies 2Antibodies for Studying NMDA Receptor Protein Expression and,Synapse-Specific Immunolabeling 2Antibodies for Studying NMDA Receptor Protein Expression and,Synapse-Specific Immunolabeling 3Antibodies for Studying NMDA Receptor Protein Expression and,Synapse-Specific Immunolabeling 4
(Date:12/2/2009)...ent at the University of Southampton,s School of O...nography Centre, Southampton (NOCS) has formally d...he deep sea. , Hall discovered the new species i...um of Natural History in Washington. Explaining th...include some of the largest crustaceans currently ...
(Date:12/1/2009)...s National Primate Research Center, Emory Universi...ic prairie voles, an important step toward unlocki...e application of this technology will enable scien...hat will help identify the brain mechanisms of soc...is advancement may also have important implication...
(Date:12/1/2009)...r,s disease, nerve cell degeneration plays a cruci...y possibly be derived from steering the generation...een published in the current issue of the renowned...ears ago, neurogenesis the process of nerve cell ...e adult brain. The textbooks asserted that dead ne...
Breaking Biology News(10 mins):King crab family bigger than ever 2Yerkes researchers create first transgenic prairie voles 2New source discovered for the generation of nerve cells in the brain 2Revolutionizing the diagnosis of serious disease 47651 1Revolutionizing the diagnosis of serious disease 47651 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 1Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 3Make Sure Your Baby is Seeing the Most Important Things in His World 47647 1Make Sure Your Baby is Seeing the Most Important Things in His World 47647 2Make Sure Your Baby is Seeing the Most Important Things in His World 47647 3Make Sure Your Baby is Seeing the Most Important Things in His World 47647 4Make Sure Your Baby is Seeing the Most Important Things in His World 47647 5
...D, a specialist in neural tissue engineering, has ...velopment Award by the National Science Foundation...f biomedical engineering at NJIT,s Newark College ...expand his research into rapid axon stretch growth... nerve cells. , In collaboration with a team of s...
...uld serve the UK for a year and oil reserves would...if efficiency in the car industry had improved at ... computer scientist will tell an audience in Manch...urber CBE, ICL Professor of Computer Engineering a...naugural Kilburn Lecture to mark Digital 60 Day t...
...ailable in French . , Montreal, 19 June 2008 S...patients to lose up to 70 percent of their excess ...dy by Dr. Nicolas Christou of the McGill Universit... that this surgery also decreases the risk of deve...esented his preliminary results yesterday at the 2...
Other Biology News:NJIT biomedical engineer receives NSF Career Development Award 2Liter of fuel would last UK 1 year if cars had kept pace with computers 2Weight-loss surgery can cut cancer risk 2
...e spatulas have been designed to save time and pro...e interested in eliminating the recycling and rest...patula is individually packaged, RNase/DNase free,...umber is a new product number, created to easily m...
...e spatulas have been designed to save time and pro...e interested in eliminating the recycling and rest...patula is individually packaged, RNase/DNase free,...umber is a new product number, created to easily m...
...e Phosphatase Detection Kit (Catalog number SCR004...pic assessment of ES cell differentiation by the d... from CHEMICON are the monoclonal antibodies TRA-2... Number MAB4354), which permit the detection of Li...
Complete 2 channel polarographic oxygen monitoring system from Instech Solomon
Biology Products: